Oncology Medical News about acute myeloid leukemia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Analysis of the Ten-Eleven Translocation (TET)2 gene in familial myeloproliferative neoplasms
Blood, 07/02/09

Saint-Martin C et al. - Analysis of familial segregation confirmed that TET2 mutations were not inherited but somatically acquired. TET2 mutations were mainly observed (10/12) in patients with primary myelofibrosis (PMF) or patients with polycythemia vera (PV) or essential thrombocythemia (ET) who secondarily evolved towards myelofibrosis or acute myeloid leukemia.

<< Previous
New mutations detected by denaturing high performance liquid...

Next >>
Plasma concentration of amrubicinol in plateau phase in patients...

Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome
Cancer, 10/29/09 Relevance Score: 82%

Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Journal of Clinical Oncology, 10/23/09 Relevance Score: 82%

Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
Current Opinion in Oncology, 10/14/09 Relevance Score: 82%

FLT3 inhibition as a targeted therapy for acute myeloid leukemia
Current Opinion in Oncology, 10/14/09 Relevance Score: 82%

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
Blood, 10/02/09 Relevance Score: 82%